ELRIG – Discovery & Development Europe 2026

Meet Myllia in Berlin – we will present our CRISPR screening platform enabling unbiased target discovery in primary human cells

Stefanie Fellinger is heading to Berlin to represent Myllia Biotechnology at Discovery & Development Europe 2026

She will present a poster titled “Pooled CRISPRi Screening in Jurkat Cells Demonstrates Robust Performance of the InTraSeq™ Workflow”, depicting how Myllia’s pooled CRISPR screenings were combined with InTraSeq™, a single-cell multimodal method that measures RNA alongside intracellular and surface proteins.

Event page: ELRIG – Discovery & Development Europe 2026